Has Jaykumar Maradia received payments from drug or device companies?

Yes. Drug and device makers reported $5,736 in general payments to Jaykumar Maradia across 212 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jaykumar Maradia did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jaykumar Maradia come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jaykumar Maradia

Psychiatric/Mental Health · Roseville, CANPI 1386254134

Payments from drug & device makers

$5,736in general payments, 2019–2025

Across 212 payments — averaging $27.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Johnson & Johnson$1K
Teva Pharmaceuticals USA, Inc.$1K
Otsuka America Pharmaceutical, Inc.$832
Neurocrine Biosciences, Inc.$501
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$293
plus $834 from 11 others

What the payments were for

Food & beverage$5,44695%
Education$2905%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	59	$1,156
Johnson & Johnson	24	$1,065
Teva Pharmaceuticals USA, Inc.	36	$1,057
Otsuka America Pharmaceutical, Inc.	34	$832
Neurocrine Biosciences, Inc.	15	$501
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$293
E.r. Squibb & Sons, L.L.C.	5	$208
Alkermes, Inc.	8	$186
Braeburn Inc.	1	$100
Lundbeck LLC	4	$80
Axsome Therapeutics, Inc.	2	$57
Indivior Inc.	3	$55
Otsuka Pharmaceutical Development & Commercialization, Inc.	2	$49
Takeda Pharmaceuticals U.S.A., Inc.	2	$41
Sage Therapeutics, LLC	1	$21
Bausch Health US, LLC	1	$20
Collegium Pharmaceutical, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,736 in reported general payments places this provider in the 90th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
UzedyRisperidone	12	$46,613
RexultiBrexpiprazole	31	$45,638
VraylarCariprazine Hcl	23	$33,498
CaplytaLumateperone Tosylate	19	$30,312
SublocadeBuprenorphine	13	$26,453
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	55	$8,882
Paliperidone ErPaliperidone	26	$4,579
Aripiprazole	39	$3,362
Sertraline Hcl	64	$1,909
Buprenorphine Hcl	32	$1,665
Duloxetine Hcl	32	$930
Bupropion XlBupropion Hcl	70	$895
Trazodone Hcl	72	$817
Quetiapine Fumarate ErQuetiapine Fumarate	25	$614
Mirtazapine	59	$499

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Teva Pharmaceuticals USA, Inc.Uzedy	$1,057	$46,61312 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$832	$45,63831 claims
AbbVieVraylar	$1,156	$33,49823 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta	$293	$30,31219 claims
Indivior Inc.Sublocade	$55	$26,45313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,433 psychiatric/mental health providers in California.

Other psychiatric/mental health in Roseville

Carey MartinMillbrae$745K
Liberty MaciasRedlands$288K
Joshua BurgettSacramento$239K
Jovita Ezirim-SalamialofojeLos Angeles$162K
Angie-Kolleen TanThousand Oaks$159K
Thy LamVista$121K
David OhIrvine$72K
Samantha PerkinsAnaheim$49K
Yvette ElpidioOrange$43K
Sarah KoLos Angeles$34K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →